跳到主要內容

臺灣博碩士論文加值系統

(44.213.63.130) 您好!臺灣時間:2023/02/03 15:19
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:洪珮玲
研究生(外文):Pei-Ling Hung
論文名稱:醫療保健人員結核桿菌感染之調查研究
論文名稱(外文):Latent TB Infection among Healthcare Workers
指導教授:辜志弘辜志弘引用關係榮建國
指導教授(外文):Chih-Hung KuJiann-Gwo Rong
學位類別:碩士
校院名稱:國防醫學院
系所名稱:公共衛生學研究所
學門:醫藥衛生學門
學類:公共衛生學類
論文種類:學術論文
論文出版年:2006
畢業學年度:94
語文別:中文
論文頁數:78
中文關鍵詞:結核桿菌感染醫療保健人員
外文關鍵詞:tuberculosis infectionQFT-G IThealthcare workers
相關次數:
  • 被引用被引用:1
  • 點閱點閱:539
  • 評分評分:
  • 下載下載:74
  • 收藏至我的研究室書目清單書目收藏:1
根據世界衛生組織(WHO)報告指出全球已有三分之一的人口感染結核桿菌,且肺結核為罹病人數最多與死亡人數最多的法定傳染病;而醫療保健人員因職業關係常需接觸病人而成為結核桿菌感染的高危險群。因此,瞭解醫療保健人員(Healthcare workers)結核桿菌感染的盛行情形與相關危險因子,實屬刻不容緩之事。
本研究為一橫斷性研究(cross-sectional study),研究對象為某醫院的醫療保健人員,依其暴露於結核桿菌之危險性分成高暴露組、中暴露組與低暴露組。此外,在通過該院人體試驗委員會後,亦針對願意提供血液檢體的研究對象採集血液樣本,並偵測血液中的interferon gamma(IFN-γ)濃度以得知該受測者是否遭受結核桿菌感染。最後以多變項邏輯式迴歸(Multiple Logistic Regression)來探討危險因子與結核桿菌感染之相關。
本研究結果發現該院醫療保健人員結核桿菌感染盛行率為11.7%(36/307)。在校正干擾因素後發現,工作年資、輪班情形及是否接種過卡介苗與結核桿菌感染有關。工作年資每增加一年其感染結核桿菌的危險性將增加7.9%(OR=1.079, 95%CI=1.029-1.131);有輪班的人感染結核桿菌的危險性是沒有輪班的人的2.7倍(OR=2.696, 95%CI=1.018-7.142);沒有施打卡介苗的人其感染結核桿菌的危險性是有打卡介苗的人的7.8倍(OR=7.822, 95%CI=1.787-34.231)。此外,在36位QFT Gold In-Tube結核桿菌感染血液檢體結果陽性者中,沒有人於問卷中自述曾經罹患過肺結核,因此該36位結核桿菌感染者是在不知不覺中感染了結核桿菌,其感染原因是否因職業而感染,需進一步探討方能得知。
據此研究結果,QFT Gold In-Tube血液檢驗結果為陽性者,建議至門診尋求醫師診斷,若為肺結核病患者則應給予治療;若不是,則建議其平時注意個人衛生清潔習慣及做好防護措施且應避免輪班工作情形,以減少其發展成肺結核病的機會。另外,建議針對新進員工實施結核桿菌感染的篩檢,並將此篩檢項目列為員工年度體檢,以降低醫療保健人員結核桿菌感染的危險性。
According to the WHO report, nearly one-third of the global population has been infected with Mycobacterium tuberculosis (TB). TB was the top one of mortality and morbidity in infectious diseases, respectively. TB is an occupational hazard to the healthcare workers; we thus conducted a cross-sectional study to assess the TB infection prevalence and risk factors among healthcare workers in Taiwan.
Study subjects were divided into three groups: high risk, middle risk, and low risk groups. Demographic data, work history, and disease history were collected by using a self-conducted structured questionnaire. Volunteer blood was also collected for diagnosis of TB infection by using QuantiFERON-TB Gold In-Tube assay (QFT-G IT). Multiple logistic regression were used to assess the association of interests, as well to adjust for potential confounders.
The prevalence of TB infection was 11.7% (36/307). After adjusting for confounders, we found that work year, shift, and BCG vaccination were associated with TB infection. With an increasing in one year of work, the risk of TB infection was increased 7.9%(OR=1.079, 95%CI=1.029-1.131). Workers with a shift job had 2.7-times(OR=2.696, 95%CI=1.018-7.142) higher risk of having a TB infection than none. Workers who did not have a BCG vaccination had 7.8-times higher risk of having a TB infection than that of BCG workers(OR=7.822, 95%CI=1.787-34.231). However, all of the 36 positive workers did not know themselves had a TB infection. Further study should be conducted to identify occupational or non-occupational infection.
We referred these 36 positive workers to a clinic for further diagnosis and treatment, and suggested more self protection and few shift work. In addition, a QFT-G IT test was recommended for new healthcare workers.
正文目錄
表目錄
圖目錄
附錄目錄
中文摘要
英文摘要
第一章 前言
第一節 研究背景
第二節 文獻探討
第三節 研究目的與假設
第二章 研究方法
第一節 研究對象
第二節 研究設計
第三節 研究架構
第四節 研究變項之操作型定義
第五節 研究工具與研究工具之信效度
第六節 資料收集方法與步驟
第七節 統計方法
第三章 結果
第一節 研究對象之人口學變項
第二節 研究對象之暴露情形
第三節 研究對象之問卷自我檢測分佈情形
第四節 醫療保健人員結核桿菌感染之盛行情形
第五節 肺結核疾病史與QFT Gold In-Tube結核桿菌感染血液檢體結果比較
第六節 結核桿菌感染之多變項分析
第七節 影響醫療保健人員結核桿菌感染之危險因素
第四章 討論
第一節 醫療保健人員結核桿菌感染盛行率之比較
第二節 肺結核疾病史與QFT Gold In-Tube結核桿菌感染血液檢體結果比較
第三節 探討醫療保健人員結核桿菌感染之危險因素
第五章 結論與建議
參考文獻
附錄一 結核菌素皮膚試驗陽性判斷標準
附錄二 QuantiFERON-TB Gold In-Tube test結果判斷標準
附錄三 潛在性肺結核感染預防性治療之標準
Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356:1099-104.

American thoracic society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000; 161:1376-95.

American thoracic society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000; 161:S221-S247.

Centers for Disease Control and Prevention(CDC). Core curriculum on tuberculosis: what the clinician should know. 2000.

Centers for Disease Control and Prevention(CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005; 54:19-20.

Centers for Disease Control and Prevention(CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005; 54:144-5.

Centers for Disease Control and Prevention(CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005; 54:145-6.

Centers for Disease Control and Prevention(CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005; 54:149-52.

Centers for Disease Control and Prevention(CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994; 43:6.

Centers for Disease Control and Prevention(CDC). Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR 2003; 52:15-8.

Centers for Disease Control and Prevention(CDC). Reported tuberculosis in the United States, 1999. 1999.

Centers for Disease Control and Prevention(CDC). Reported tuberculosis in the United States, 2003. 2004.

Cuhadaroglu C, Erelel M, Tabak L, Kilicaslan Z. Increased risk of tuberculosis in health care workers: a retrospective survey at a teaching hospital in Istanbul, Turkey. BMC Infect Dis 2002; 2:14.

Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7:77.

Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullan JV, Jarvis WR, Bloch AB, Cauthen GM. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992; 267:2632-4.

Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999; 282:677-86.

Food and Drug Administration, Center for Devices and Radiological Health. QuantiFERON®-TB-P010033 [Letter]. Rockville, MD: Food and Drug Administration, 2002.

Fraser VJ, Kilo CM, Bailey TC, Medoff G, Dunagan WC. Screening of physicians for tuberculosis. Infect Control Hosp Epidemiol 1994; 15: 95-100.

Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-6.

Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006; 27:442-8.

Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuber Lung Dis 1996; 77:391-400.

Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol 2003; 32:794-9.

Long R, Njoo H, Hershfield E. Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ 1999; 160:1185-90.

Louther J, Rivera P, Feldman J, Villa N, Dehovitz J, Sepkowitz KA. Risk of tuberculin conversion according to occupation among health care workers at a New York City hospital. Am J Respir Crit Med 1997; 156:201-5.

MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NMH. Impact of tuberculosis control measures and crowding on the incidence of tuberculosis infection in Maryland prisons. Clin Infect Dis 1997; 24:1060-7.

Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286:1740-7.

Menzies D, Fanning A, Yuan L, Fitzgerald JM, and the Canadian collaborative group in nosocomial transmission of TB. Hospital ventilation and risk for tuberculosis infection in Canadian health care workers. Ann Intern Med 2000; 133:779-89.

Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I. Specific detection of tuberculosis infection an interferon-gamma based assay using new antigens. Am J Respir Crit Care Med 2004; 170:59-64.

Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reinglod AL, Riley LW, Colford JM. Mycobacterium tuberculosis infection in health care workers in rural India. JAMA 2005; 293:2746-55.

Schatz A, Waksman SA. Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. Proc Soc Exp Biol Med 1944; 57:244-8.

Thorson A, Diwan VK. Gender inequalities in tuberculosis: aspects of infection, notification rates, and compliance. Curr Opin Pulm Med 2001; 7:165-9.

Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997; 119:183-201.

World Health Organization(WHO). Global tuberculosis control: surveillance, planning, financing. WHO report 2006. Geneva, World Health Organization(WHO/HTM/TB/2006.362).

World Health Organization(WHO). Guidelines for HIV surveillance among tuberculosis patients. Geneva, World Health Organization, 1994(WHO/TB/94.180).

World Health Organization(WHO). Guidelines for workplace TB control activities: the contribution of workplace TB control activities to TB control in the community. WHO/CDS/TB/2003.323

World Health Organization(WHO). WHO tuberculosis programme: framework for effective tuberculosis control. WHO 1994. Geneva, World Health Organization(WHO/TB/94.179).

行政院衛生署:台灣地區主要死因死亡率趨勢圖,2004。摘自http://www.doh.gov.tw/statistic/data/死因摘要/93年/93.htm

行政院衛生署:九十三年台灣主要死亡原因,2004。摘自http://www.doh.gov.tw/statistic/data/死因摘要/93年/93.htm

沈光漢,兩階段式結核菌素皮膚試驗及QuantiFERON-TB Gold試驗之比較研究,行政院衛生署疾病管制局結核病學術研討會報告 p40,2005。

林道平,結核病防治年報-1997,台灣省慢性病防治局,1998。

林獻鋒、賴世偉、張靖梅、劉秋松,肺結核,基層醫學,17:78-84,2002。

金傳春,肺結核捲土重來的省思,科學月刊,28:272-5,1997。

疾病管制局:九十三年度台灣地區法定傳染病統計年報表,2004。摘自http://www.cdc.gov.tw/index_info_info.asp?data_id=592

疾病管制局:中央傳染病追蹤監視系統/結核病流行病學專區/歷年結核病發生率,2004。摘自http://203.65.72.83/ch/dt/upload/QC/epi/epi_face.htm

疾病管制局:台灣歷年結核病死亡率,2005.。摘自http://203.65.72.83/ch/dt/upload/90TB_epi/台灣歷年結核病死亡率.htm

陸坤泰,結核病新知,台灣醫學,1:43-9,1997。

勞工安全衛生法,1991。

勞工安全衛生研究所,醫護人員請小心肺結核感染,新聞稿,2002。

張靜文,醫護人員能免於肺結核感染嗎,勞工安全衛生簡訊32,1998。

黃吉志,結核病的歷史回顧與展望,高醫醫訊25,2005。

劉雨田,分枝桿菌,新編微生物學,台北市:永大,277-81,1991。

鄭舒倖、黃婉瑩、莊意芬、劉勝芬、索任、陳重達,醫療保健人員結核菌素測驗陽性之意義,感染控制雜誌,14:140-8,2004。

閻啟泰、蘇慶華、商惠芳、楊定一,分枝桿菌,微生物學,台北市:匯華, 288-93,2000。
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top